Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy

被引:187
作者
Bailey, CK
Andriola, IFM
Kampinga, HH
Merry, DE
机构
[1] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA
[2] Univ Penn, Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA
[3] Univ Groningen, Dept Radiat & Stress Cell Biol, Groningen, Netherlands
关键词
D O I
10.1093/hmg/11.5.515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spinal and bulbar muscular atrophy (SBMA) is one of a growing number of neurodegenerative diseases caused by a polyglutamine-encoding CAG trinucleotide repeat expansion, and is caused by an expansion within exon 1 of the androgen receptor (AR) gene. The family of polyglutamine diseases is characterized by the presence of ubiquitinated, intranuclear inclusions associated with molecular chaperones and 26S proteasome components, although the role of these inclusions in the pathogenesis of polyglutamine diseases remains unclear. The over-expression of molecular chaperones of the Hsp70 and Hsp40 families has been shown to modulate inclusion frequency and cellular toxicity. We developed a cell culture system which enables the quantitative analysis of the effects of molecular chaperones on the biochemical properties of an expanded repeat AR. Using this approach, we demonstrate that Hsp70 and its co-chaperone Hsp40 not only increase expanded repeat AR solubility, but function to enhance the degradation of expanded repeat AR through the proteasome. Furthermore, our studies indicate that these molecular chaperones significantly decrease the half-life of an expanded repeat AR. Molecular chaperone enhancement of protein degradation points to the modulation of molecular chaperones as a potential therapeutic target for polyglutamine diseases.
引用
收藏
页码:515 / 523
页数:9
相关论文
共 46 条
[1]   Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice [J].
Abel, A ;
Walcott, J ;
Woods, J ;
Duda, J ;
Merry, DE .
HUMAN MOLECULAR GENETICS, 2001, 10 (02) :107-116
[2]  
Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
[3]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[4]  
Bercovich B, 1997, J BIOL CHEM, V272, P9002
[5]   Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro [J].
Chai, YH ;
Koppenhafer, SL ;
Shoesmith, SJ ;
Perez, MK ;
Paulson, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :673-682
[6]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[7]   Mechanisms of chaperone suppression of polyglutamine disease:: selectivity, synergy and medullation of protein solubility in Drosophila [J].
Chan, HYE ;
Warrick, JM ;
Gray-Board, GL ;
Paulson, HL ;
Bonini, NM .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2811-2820
[8]   The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].
Connell, P ;
Ballinger, CA ;
Jiang, JH ;
Wu, YX ;
Thompson, LJ ;
Höhfeld, J ;
Patterson, C .
NATURE CELL BIOLOGY, 2001, 3 (01) :93-96
[9]   Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice [J].
Cummings, CJ ;
Reinstein, E ;
Sun, YL ;
Antalffy, B ;
Jiang, YH ;
Ciechanover, A ;
Orr, HT ;
Beaudet, AL ;
Zoghbi, HY .
NEURON, 1999, 24 (04) :879-892
[10]   Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice [J].
Cummings, CJ ;
Sun, YL ;
Opal, P ;
Antalffy, B ;
Mestril, R ;
Orr, HT ;
Dillmann, WH ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2001, 10 (14) :1511-1518